Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphanie Germon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal for Parasitology|February 19, 2011
Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninumSarah Dion, Stéphanie Germon, Rachel Guiton, et al.
Memorias Do Instituto Oswaldo Cruz|March 15, 2012
Depletion of CD25⁺ cells during acute toxoplasmosis does not significantly increase mortality in Swiss OF1 miceHaroon Akbar, Stéphanie Germon, Patricia Berthon, et al.
Journal of Molecular Biology|July 5, 2005
Mariner Mos1 transposase dimerizes prior to ITR bindingCorinne Augé-Gouillou, Benjamin Brillet, Stéphanie Germon, et al.
Medecine Sciences : M/S|January 25, 2021
[Antitumoral microorganisms: The Swiss army knife of immunotherapy]Loïs Coënon, Arthur Battistoni, Agathe Poupée-Beaugé, et al.
Genetica|June 18, 2009
Mariner Mos1 transposase optimization by rational mutagenesisStéphanie Germon, Nicolas Bouchet, Sophie Casteret, et al.
Future Microbiology|March 25, 2017
Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in miceCéline Ducournau, Thi Tl Nguyen, Rodolphe Carpentier, et al.
Molecular Therapy. Oncology|April 16, 2025
<i>Neospora caninum</i> as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapyClément Riviere, Muna Aljieli, Marie-Noëlle Mévélec, et al.
Journal for Immunotherapy of Cancer|December 1, 2020
<i>Neospora caninum:</i> a new class of biopharmaceuticals in the therapeutic arsenal against cancerLouis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal for Parasitology|February 19, 2011
Functional activation of T cells by dendritic cells and macrophages exposed to the intracellular parasite Neospora caninumSarah Dion, Stéphanie Germon, Rachel Guiton, et al.
Memorias Do Instituto Oswaldo Cruz|March 15, 2012
Depletion of CD25⁺ cells during acute toxoplasmosis does not significantly increase mortality in Swiss OF1 miceHaroon Akbar, Stéphanie Germon, Patricia Berthon, et al.
Journal of Molecular Biology|July 5, 2005
Mariner Mos1 transposase dimerizes prior to ITR bindingCorinne Augé-Gouillou, Benjamin Brillet, Stéphanie Germon, et al.
Medecine Sciences : M/S|January 25, 2021
[Antitumoral microorganisms: The Swiss army knife of immunotherapy]Loïs Coënon, Arthur Battistoni, Agathe Poupée-Beaugé, et al.
Genetica|June 18, 2009
Mariner Mos1 transposase optimization by rational mutagenesisStéphanie Germon, Nicolas Bouchet, Sophie Casteret, et al.
Future Microbiology|March 25, 2017
Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in miceCéline Ducournau, Thi Tl Nguyen, Rodolphe Carpentier, et al.
Molecular Therapy. Oncology|April 16, 2025
<i>Neospora caninum</i> as delivery vehicle for anti-PD-L1 scFv-Fc: A novel approach for cancer immunotherapyClément Riviere, Muna Aljieli, Marie-Noëlle Mévélec, et al.
Journal for Immunotherapy of Cancer|December 1, 2020
<i>Neospora caninum:</i> a new class of biopharmaceuticals in the therapeutic arsenal against cancerLouis Lantier, Agathe Poupée-Beaugé, Anne di Tommaso, et al.
Pageof 1